Insider Title Company Date Price Return Shares Value
Schatzman Randall C Chief Executive Officer Bolt Biotherapeutics, Inc. (BOLT) 2021-02-09 $400.00 -99.8% 75 $30,000
Return Profit / (loss) Cost
Total -99.8% $-29,951 $30,000